← 產業報告目錄

Microbiology Testing Market by Product [Instrument, Reagent & Kit, Consumable], Technology [Traditional (Manual Counting, Culture), Rapid (Nucleic Acid, Viability)], End User [Pharma, Biotech, Food, Water, Environmental Testing]-Global Forecast to 2031

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2026-02-12頁數 321報告編號 HIT10240

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global microbiology testing market is projected to reach USD 10.09 billion by 2031, up from USD 7.79 billion in 2026, at a CAGR of 5.3% during the forecast period. The market is expected to grow rapidly due to rising contamination risks in the food, water, and environmental sectors, increased industrial production, and advances in testing technologies. A growing focus on contamination control, regulatory compliance, and product safety, along with innovations in rapid testing and automation, is driving demand for accurate and reliable microbiology testing solutions. However, concerns about the cost of advanced testing systems and variability in low-cost solutions may restrain market growth. Nonetheless, continuous improvements in testing methodologies, coupled with increasing adoption across various industries, are expected to fuel market expansion. The pharmaceutical & biotech companies segment is expected to have the largest market during the forecast period. By end user, the market is segmented into pharmaceutical & biotech companies, food & beverage companies, environmental & water testing, cosmetics & personal-care companies, and other end users. In 2025, pharmaceutical & biotech companies accounted for the largest share of the market. The pharmaceutical & biotech segment is the largest in the microbiology testing market due to the critical need for contamination control, product safety, and regulatory compliance across drug manufacturing and biotechnological research. These industries rely heavily on microbiological testing to ensure the sterility, quality, and safety of their products, particularly biologics, vaccines, and therapeutic compounds. Stringent regulatory requirements, such as those from the FDA and EMA, mandate rigorous microbial testing at every stage of production, from raw material validation to final product release. Furthermore, the growing prevalence of diseases and the need for new treatments and therapies continue to drive significant demand for microbiology testing solutions, making pharmaceutical & biotech companies the largest consumers of these services. The bacterial products segment accounted for the largest market share in the microbiology testing market. The microbiology testing market is segmented by pathogen type into bacterial, viral, fungal, and other pathogens. The bacterial segment is the largest within this category due to the widespread presence and impact of bacterial contamination across various industries. Bacteria are among the most common pathogens in contamination issues across sectors such as food and beverage, water treatment, and environmental monitoring. Their ability to cause spoilage, disease, and quality issues drives strong demand for bacterial testing to ensure product safety, regulatory compliance, and public health. Additionally, well-established, reliable methods for detecting and identifying bacterial pathogens, along with regulatory mandates, further strengthen the dominance of the bacterial segment in microbiology testing. The Asia Pacific is expected to be the fastest-growing market for microbiology testing during the forecast period. The global microbiology testing market is segmented into six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa. The Asia Pacific is the fastest-growing market in the microbiology testing sector, driven by rapid industrialization, rising healthcare investments, and a growing focus on contamination control across industries. The region is seeing strong growth in sectors such as food and beverage, water treatment, and environmental monitoring, all of which require extensive microbiological testing to ensure safety and regulatory compliance. Additionally, improving healthcare infrastructure, coupled with rising awareness of food safety and public health, is driving demand for testing solutions. Government initiatives and regulatory developments in countries such as China, India, and across Southeast Asia further support market growth, while the adoption of advanced and automated microbiology testing technologies helps streamline operations and improve accuracy. These factors collectively position Asia-Pacific as the fastest-growing market for microbiology testing. North America is the leading market for microbiology testing, driven by a strong regulatory framework that creates high demand for testing to ensure product safety and compliance. The region is a leader in adopting advanced, automated testing solutions that improve efficiency and accuracy. Additionally, North America's diverse industries, including pharmaceuticals, biotechnology, food, and water, continually require reliable microbiology testing. The region's well-established healthcare and industrial infrastructure, combined with significant investments in research and development, further solidifies its position as the market leader. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30% • By Designation: C Level: 27%, Director Level: 18%, and Others: 55% • By Region: North America: 51%, Europe: 21%, Asia Pacific: 18%, Latin America: 6%, and Middle East & Africa: 4% • Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion. Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs. Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers. The major players operating in the microbiology testing market are bioMérieux (France), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), and Neogen Corporation (US). Research Coverage This report examines the microbiology testing market by product, technology, pathogen type, end user, and region. It also examines key factors (drivers, restraints, opportunities, and challenges) influencing market growth and provides an in-depth analysis of the competitive landscape among market leaders. Furthermore, the report analyzes micro-markets by their individual growth trends. It forecasts market segment revenue for five major regions (and the respective countries within each region). Reasons to Buy the Report The report will enable established firms and smaller entrants to gauge the market’s pulse, which, in turn, will help them gain a larger market share. Firms purchasing the report could use one or more of the strategies listed below to strengthen their market presence. This report provides insights into the following pointers:  Analysis of key Drivers (Technological advancements in rapid microbiology testing, Increased funding for R&D, Rising food recalls due to non-compliant food products, Rising demand from cosmetics & personal care industry)  Restraints (Complexity in testing techniques, High Capital investments, and low cost benefit ratio)  Opportunities (Popularity of digital and automated testing platforms, Technological advancements in the testing industry)  Challenges (Operational barriers, Increasing cost of procuring microbiology testing equipment) Market Penetration: Comprehensive information on the product portfolios offered by the top players in the microbiology testing market Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the microbiology testing market Market Development: Comprehensive information on lucrative emerging regions Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the microbiology testing market Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players, such as bioMérieux (France), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), and Neogen Corporation (US)
目錄 Table of Contents
1 INTRODUCTION 30 1.1 STUDY OBJECTIVES 30 1.2 MARKET DEFINITION 30 1.3 STUDY SCOPE 31 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 31 1.3.2 INCLUSIONS AND EXCLUSIONS 32 1.3.3 YEARS CONSIDERED 33 1.4 CURRENCY CONSIDERED 33 1.5 STAKEHOLDERS 33 2 EXECUTIVE SUMMARY 34 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 34 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 35 2.3 DISRUPTIVE TRENDS SHAPING MARKET 35 2.4 FASTEST-GROWTH SEGMENTS AND EMERGING FRONTIERS 36 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 37 3 PREMIUM INSIGHTS 38 3.1 MICROBIOLOGY TESTING MARKET OVERVIEW 38 3.2 MICROBIOLOGY TESTING MARKET, BY PRODUCT 38 3.3 MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY 39 3.4 MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE 39 3.5 MICROBIOLOGY TESTING MARKET, BY END USER 40 3.6 MICROBIOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 40 4 MARKET OVERVIEW 41 4.1 INTRODUCTION 41 4.2 MARKET DYNAMICS 41 4.2.1 DRIVERS 41 4.2.1.1 Technological advancements in rapid microbiology testing 41 4.2.1.2 Increased funding for R&D 42 4.2.1.3 Rising food recalls due to non-compliant food products 42 4.2.1.4 Rising demand from cosmetics & personal care industry 45 4.2.2 RESTRAINTS 45 4.2.2.1 Complexity in testing techniques 45 4.2.2.2 High Capital investments and low cost-benefit ratio 46 4.2.3 OPPORTUNITIES 46 4.2.3.1 Popularity of digital and automated testing platforms 46 4.2.3.2 Technological advancements in testing industry 46 4.2.4 CHALLENGES 47 4.2.4.1 Operational barriers 47 4.2.4.2 Increasing cost of procuring microbiology testing equipment 48 4.3 UNMET NEEDS AND WHITE SPACES 48 4.3.1 UNMET NEEDS IN MICROBIOLOGY TESTING MARKET 48 4.3.2 WHITE SPACE OPPORTUNITIES 49 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 50 4.4.1 INTERCONNECTED MARKETS 50 4.4.2 CROSS-SECTOR OPPORTUNITIES 50 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 51 4.5.1 KEY MOVES AND STRATEGIC FOCUS 51 5 INDUSTRY TRENDS 52 5.1 PORTER’S FIVE FORCES ANALYSIS 52 5.1.1 THREAT OF NEW ENTRANTS 53 5.1.2 THREAT OF SUBSTITUTES 53 5.1.3 BARGAINING POWER OF BUYERS 53 5.1.4 BARGAINING POWER OF SUPPLIERS 54 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 54 5.2 MACROECONOMIC INDICATORS 54 5.2.1 INTRODUCTION 54 5.2.2 GDP TRENDS AND FORECAST 54 5.3 SUPPLY CHAIN ANALYSIS 57 5.4 VALUE CHAIN ANALYSIS 58 5.5 ECOSYSTEM ANALYSIS 59 5.6 PRICING ANALYSIS 61 5.6.1 AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING, BY PRODUCT 61 5.6.2 AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING PRODUCTS, BY KEY PLAYER 61 5.6.3 AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING PRODUCTS, BY REGION 62 5.7 TRADE ANALYSIS 63 5.7.1 IMPORT SCENARIO (HS CODE 3822) 63 5.7.2 EXPORT SCENARIO (HS CODE 3822) 63 5.8 KEY CONFERENCES & EVENTS, 2026–2027 64 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 65 5.10 INVESTMENT & FUNDING SCENARIO 65 5.11 CASE STUDY ANALYSIS 66 5.11.1 YOUNGS SEAFOOD ACCELERATED FOOD TESTING WITH VIDAS 66 5.11.2 RAPID MICROBIOLOGICAL METHOD CASE STUDY FOR ADVANCED THERAPY MEDICINAL PRODUCTS 67 5.11.3 RAPID DETECTION METHOD OF BACTERIAL PATHOGENS IN SURFACE WATERS AND NEW RISK INDICATOR FOR WATER PATHOGENIC POLLUTION 67 5.12 IMPACT OF 2025 US TARIFFS ON MICROBIOLOGY TESTING MARKET 68 5.12.1 INTRODUCTION 68 5.12.2 KEY TARIFF RATES 68 5.12.3 PRICE IMPACT ANALYSIS 69 5.12.4 KEY IMPACT ON COUNTRY/REGION 69 5.12.4.1 North America 69 5.12.4.2 Europe 69 5.12.4.3 Asia Pacific 69 5.12.5 IMPACT ON END-USE INDUSTRIES 70 5.12.5.1 Pharmaceutical & biotech companies 70 5.12.5.2 Food & beverage companies 70 5.12.5.3 Environmental & water testing 70 5.12.5.4 Cosmetics & personal care companies 70 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 71 6.1 KEY EMERGING TECHNOLOGIES 71 6.1.1 AUTOMATED MULTIPLEX PCR SYSTEMS 71 6.1.2 BIOSENSORS 71 6.2 COMPLEMENTARY TECHNOLOGIES 72 6.2.1 FOOD & WATER SAFETY MONITORING TOOLS 72 6.2.2 ANTIMICROBIAL RESISTANCE TESTING 72 6.3 TECHNOLOGY/PRODUCT ROADMAP 72 6.4 PATENT ANALYSIS 73 6.5 FUTURE APPLICATION 74 6.6 IMPACT OF AI/GENERATIVE AI ON MICROBIOLOGY TESTING MARKET 75 6.6.1 INTRODUCTION 75 6.6.2 TOP USE CASES AND MARKET POTENTIAL 75 6.6.3 USE CASE 76 6.6.3.1 Adoption of Gen AI by CarbConnect to achieve accuracy and consistency in diagnostics 76 6.6.4 EVOLVING ADJACENT ECOSYSTEM THROUGH ADOPTION OF GEN AI 76 7 SUSTAINABILITY AND REGULATORY LANDSCAPE 78 7.1 REGIONAL REGULATIONS AND COMPLIANCE 78 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 7.1.2 INDUSTRY STANDARDS 80 7.2 SUSTAINABILITY INITIATIVES 81 7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN MICROBIOLOGY TESTING 81 7.2.1.1 Eco-friendly initiatives 81 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 82 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 83 8.1 DECISION-MAKING PROCESS 83 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 83 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 83 8.2.2 BUYING CRITERIA 84 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 85 8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 86 8.5 MARKET PROFITABILITY 87 8.5.1 REVENUE POTENTIAL 87 8.5.2 COST DYNAMICS 87 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 87 9 MICROBIOLOGY TESTING MARKET, BY PRODUCT 88 9.1 INTRODUCTION 89 9.2 INSTRUMENTS 89 9.2.1 WIDESPREAD ADOPTION OF AUTOMATED AND HIGH-THROUGHPUT LABORATORY INSTRUMENTS TO SUPPORT MICROBIOLOGY TESTING DEMAND 89 9.2.2 INCUBATORS 93 9.2.2.1 Controlled environmental conditions to enable reliable microbial growth and detection 93 9.2.3 MICROSCOPES 96 9.2.3.1 Direct visualization and morphological analysis of microorganisms 96 9.2.4 COLONY COUNTERS 98 9.2.4.1 Accurate enumeration of microbial colonies to support quality assurance 98 9.2.5 MASS SPECTROMETERS 100 9.2.5.1 Rapid and accurate microbial identification through advanced mass spectrometry methods 100 9.2.6 AUTOMATED CULTURE SYSTEMS 102 9.2.6.1 High-throughput systems supporting standardized microbiology workflows 102 9.2.7 OTHER INSTRUMENTS 105 9.3 REAGENTS & KITS 107 9.3.1 HIGH RECURRING DEMAND FOR STANDARDIZED AND READY-TO-USE REAGENTS & KITS TO SUPPORT MARKET GROWTH 107 9.4 CONSUMABLES 111 9.4.1 CONSISTENT HIGH-VOLUME CONSUMPTION OF DISPOSABLE LABORATORY SUPPLIES TO FUEL ROUTINE MICROBIOLOGY TESTING MARKET 111 10 MICROBIOLOGY TESTING MARKET: VOLUME ANALYSIS 116 10.1 INTRODUCTION 116 10.2 US: VOLUME OF PHARMA INCUBATOR INSTALLED BASE 116   11 MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY 117 11.1 INTRODUCTION 118 11.2 TRADITIONAL MICROBIOLOGY METHODS (TMM) 118 11.2.1 WIDESPREAD REGULATORY ACCEPTANCE AND COST-EFFECTIVENESS TO SUPPORT CONTINUED ADOPTION 118 11.2.2 CULTURE METHODS 122 11.2.2.1 Continued reliance on culture-based techniques to support routine microbiology testing 122 11.2.3 MICROSCOPY METHODS 125 11.2.3.1 Rapid preliminary microbial screening to support contamination investigations 125 11.2.4 MANUAL COUNTING METHODS 127 11.2.4.1 Regulatory acceptance of plate count techniques to maintain widespread usage 127 11.2.5 STAINING TECHNIQUES 130 11.2.5.1 Low-cost and effective microbial differentiation methods to support quality control 130 11.2.6 OTHER TRADITIONAL MICROBIOLOGY METHODS 132 11.3 RAPID MICROBIOLOGY METHODS (RMM) 135 11.3.1 RAPID MICROBIOLOGY METHODS ENABLE FASTER CONTAMINATION DETECTION AND IMPROVED TESTING EFFICIENCY 135 11.3.2 GROWTH-BASED RAPID MICROBIOLOGY TESTING 139 11.3.2.1 Growing demand for growth-based rapid microbiology testing to drive market growth 139 11.3.3 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING 142 11.3.3.1 High level of sensitivity, accuracy, and specificity associated with this method to boost market 142 11.3.4 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING 145 11.3.4.1 High accuracy associated with nucleic acid-based methods to favor market growth 145 11.3.5 VIABILITY-BASED RAPID MICROBIOLOGY TESTING 148 11.3.5.1 Near real-time detection and improved accuracy to drive demand 148 12 MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE 152 12.1 INTRODUCTION 153 12.2 BACTERIAL 153 12.2.1 WIDESPREAD OCCURRENCE OF BACTERIAL CONTAMINATION ACROSS INDUSTRIES TO SUPPORT MARKET DOMINANCE 153 12.3 VIRAL 155 12.3.1 INCREASING FOCUS ON VIRAL SAFETY AND ENVIRONMENTAL SURVEILLANCE TO DRIVE SEGMENT GROWTH 155 12.4 FUNGAL 157 12.4.1 RISING INCIDENCE OF YEAST AND MOLD CONTAMINATION TO FUEL TESTING DEMAND 157 12.5 OTHER PATHOGENS 159 13 MICROBIOLOGY TESTING MARKET, BY END USER 162 13.1 INTRODUCTION 163 13.2 PHARMACEUTICAL & BIOTECH COMPANIES 163 13.2.1 STRINGENT GMP AND CONTAMINATION CONTROL REQUIREMENTS TO DRIVE TESTING DEMAND 163 13.3 FOOD & BEVERAGE COMPANIES 166 13.3.1 STRINGENT FOOD SAFETY REGULATIONS AND QUALITY CONTROL TO SUPPORT MARKET GROWTH 166 13.4 ENVIRONMENTAL & WATER TESTING 168 13.4.1 GROWING FOCUS ON WATER SAFETY AND ENVIRONMENTAL MONITORING TO DRIVE DEMAND 168 13.5 COSMETICS & PERSONAL CARE COMPANIES 171 13.5.1 MICROBIAL SAFETY AND PRODUCT STABILITY REQUIREMENTS TO SUPPORT MARKET GROWTH 171 13.6 OTHER END USERS 173 14 MICROBIOLOGY TESTING MARKET, BY REGION 177 14.1 INTRODUCTION 178 14.2 NORTH AMERICA 178 14.2.1 US 181 14.2.1.1 Increasing adoption of technologically advanced products in US to favor market growth 181 14.2.2 CANADA 183 14.2.2.1 Favorable environment for R&D to drive market 183 14.3 EUROPE 185 14.3.1 GERMANY 188 14.3.1.1 Increase in investments and funding by government to fuel market growth 188 14.3.2 UK 190 14.3.2.1 High prevalence of contaminated food to drive market 190 14.3.3 FRANCE 192 14.3.3.1 Rise in R&D expenditure to favor market growth 192 14.3.4 ITALY 194 14.3.4.1 Increased adoption of advanced diagnostic technologies and growing government healthcare investments to drive market 194 14.3.5 SPAIN 196 14.3.5.1 Water monitoring mandate to boost market growth 196 14.3.6 REST OF EUROPE 198 14.4 ASIA PACIFIC 200 14.4.1 CHINA 204 14.4.1.1 High-profile contamination events and export standards to propel market 204 14.4.2 JAPAN 206 14.4.2.1 Stringent safety laws and foodborne outbreaks to accelerate market 206 14.4.3 INDIA 208 14.4.3.1 Growth in private and public investments in healthcare systems to drive adoption of microbiology testing products 208 14.4.4 SOUTH KOREA 210 14.4.4.1 Increasing demand for infection control products to support market growth 210 14.4.5 AUSTRALIA 212 14.4.5.1 Increase in awareness about antimicrobial resistance to fuel market 212 14.4.6 REST OF ASIA PACIFIC 214 14.5 LATIN AMERICA 216 14.5.1 BRAZIL 218 14.5.1.1 Need for manufacturers to comply with ANVISA’s rules to drive demand 218 14.5.2 MEXICO 220 14.5.2.1 Expanding microbiology testing capacity through trade and food safety enforcement to drive market 220 14.5.3 REST OF LATIN AMERICA 222 14.6 MIDDLE EAST & AFRICA 224 15 COMPETITIVE LANDSCAPE 227 15.1 OVERVIEW 227 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 227 15.3 REVENUE ANALYSIS, 2022–2024 228 15.4 MARKET SHARE ANALYSIS, 2025 229 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 232 15.5.1 STARS 232 15.5.2 EMERGING LEADERS 232 15.5.3 PERVASIVE PLAYERS 232 15.5.4 PARTICIPANTS 232 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 234 15.5.5.1 Company footprint 234 15.5.5.2 Regional footprint 234 15.5.5.3 Product footprint 235 15.5.5.4 Technology footprint 235 15.5.5.5 End user footprint 236 15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 237 15.6.1 PROGRESSIVE COMPANIES 237 15.6.2 RESPONSIVE COMPANIES 237 15.6.3 DYNAMIC COMPANIES 237 15.6.4 STARTING BLOCKS 237 15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 239 15.6.5.1 List of startups/SMEs 239 15.6.5.2 Competitive benchmarking of startups/SMEs 239 15.6.5.2.1 Competitive benchmarking of startups/SMEs (1/2) 239 15.6.5.2.2 Competitive benchmarking of startups/SMEs (2/2) 240 15.7 COMPANY VALUATION AND FINANCIAL METRICS 240 15.8 BRAND/PRODUCT COMPARISON 241 15.9 COMPETITIVE SCENARIO 242 15.9.1 PRODUCT LAUNCHES AND APPROVALS 242 15.9.2 DEALS 243 15.9.3 EXPANSIONS 243 16 COMPANY PROFILES 244 16.1 KEY PLAYERS 244 16.1.1 BIOMÉRIEUX 244 16.1.1.1 Business overview 244 16.1.1.2 Products offered 245 16.1.1.3 Recent developments 246 16.1.1.3.1 Product launches and approvals 246 16.1.1.3.2 Deals 247 16.1.1.4 MnM view 248 16.1.1.4.1 Right to win 248 16.1.1.4.2 Strategic choices 248 16.1.1.4.3 Weaknesses and competitive threats 248 16.1.2 THERMO FISHER SCIENTIFIC INC. 249 16.1.2.1 Business overview 249 16.1.2.2 Products offered 250 16.1.2.3 Recent developments 251 16.1.2.3.1 Product launches & approvals 251 16.1.2.4 MnM view 251 16.1.2.4.1 Right to win 251 16.1.2.4.2 Strategic choices 252 16.1.2.4.3 Weaknesses and competitive threats 252 16.1.3 MERCK KGAA 253 16.1.3.1 Business overview 253 16.1.3.2 Products/Services offered 254 16.1.3.3 Recent developments 255 16.1.3.3.1 Product launches 255 16.1.3.3.2 Deals 255 16.1.3.3.3 Expansions 256 16.1.3.4 MnM view 256 16.1.3.4.1 Right to win 256 16.1.3.4.2 Strategic choices 257 16.1.3.4.3 Weaknesses and competitive threats 257   16.1.4 BECTON, DICKINSON AND COMPANY (BD) 258 16.1.4.1 Business overview 258 16.1.4.2 Products offered 260 16.1.4.3 Recent developments 260 16.1.4.3.1 Expansions 260 16.1.4.4 MnM view 261 16.1.4.4.1 Right to win 261 16.1.4.4.2 Strategic choices 261 16.1.4.4.3 Weaknesses and competitive threats 261 16.1.5 NEOGEN CORPORATION 262 16.1.5.1 Business overview 262 16.1.5.2 Products/Services offered 263 16.1.5.3 Recent developments 264 16.1.5.3.1 Product/Service launches and approvals 264 16.1.5.3.2 Deals 265 16.1.5.4 MnM view 265 16.1.5.4.1 Right to win 265 16.1.5.4.2 Strategic choices 265 16.1.5.4.3 Weaknesses and competitive threats 265 16.1.6 QIAGEN 266 16.1.6.1 Business overview 266 16.1.6.2 Products offered 267 16.1.6.3 Recent developments 268 16.1.6.3.1 Product launches 268 16.1.7 BIO-RAD LABORATORIES, INC. 269 16.1.7.1 Business overview 269 16.1.7.2 Products/Services offered 270 16.1.7.3 Recent developments 271 16.1.7.3.1 Product launches 271 16.1.8 BRUKER 272 16.1.8.1 Business overview 272 16.1.8.2 Products/Services offered 273 16.1.8.3 Recent developments 274 16.1.8.3.1 Deals 274 16.1.9 SHIMADZU CORPORATION 275 16.1.9.1 Business overview 275 16.1.9.2 Products/Services offered 276 16.1.9.3 Recent developments 277 16.1.9.3.1 Product/Service launches and approvals 277 16.1.9.3.2 Expansions 277 16.1.10 CHARLES RIVER LABORATORIES 278 16.1.10.1 Business overview 278 16.1.10.2 Products/Services offered 279 16.1.10.3 Recent developments 280 16.1.10.3.1 Product/Service launches and approvals 280 16.1.11 EUROFINS SCIENTIFIC 281 16.1.11.1 Business overview 281 16.1.11.2 Products/Services offered 282 16.1.11.3 Recent developments 283 16.1.11.3.1 Deals 283 16.1.12 IDEXX 284 16.1.12.1 Business overview 284 16.1.12.2 Products/Services offered 285 16.1.12.3 Recent developments 286 16.1.12.3.1 Product/Service launches and approvals 286 16.2 OTHER PLAYERS 287 16.2.1 HARDY DIAGNOSTICS 287 16.2.2 CHARM SCIENCES 288 16.2.3 MICROBIOLOGICS 289 16.2.4 LIOFILCHEM S.R.L. 290 16.2.5 R-BIOPHARM 291 16.2.6 ROMER LABS DIVISION HOLDING 292 16.2.7 HYGIENA LLC 293 16.2.8 HIMEDIA LABORATORIES 294 16.2.9 CONDALAB 295 16.2.10 E&O LABORATORIES LTD 296 16.2.11 MAST GROUP LTD. 297 16.2.12 MEDICAL WIRE & EQUIPMENT 298 16.2.13 HACH 299 17 RESEARCH METHODOLOGY 300 17.1 RESEARCH DATA 300 17.2 RESEARCH APPROACH 300 17.2.1 SECONDARY DATA 301 17.2.1.1 Key secondary sources 301 17.2.1.2 Key data from secondary sources 302 17.2.2 PRIMARY DATA 303 17.2.2.1 Primary sources 303 17.2.2.2 Key data from primary sources 304 17.2.2.3 Key industry insights 305 17.2.2.4 Breakdown of primary interviews 306 17.3 MARKET SIZE ESTIMATION 306 17.3.1 BOTTOM-UP APPROACH 307 17.3.1.1 Approach 1: Company revenue estimation approach 307 17.3.1.2 Approach 2: Presentations of companies and primary interviews 307 17.3.1.3 Growth forecast 308 17.3.1.4 CAGR projections 308 17.3.2 TOP-DOWN APPROACH 309 17.4 DATA TRIANGULATION 310 17.5 MARKET SHARE ASSESSMENT 310 17.6 RESEARCH ASSUMPTIONS 311 17.6.1 PARAMETRIC ASSUMPTIONS 311 17.7 RESEARCH LIMITATIONS 311 17.8 RISK ASSESSMENT 312 18 APPENDIX 313 18.1 DISCUSSION GUIDE 313 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 317 18.3 CUSTOMIZATION OPTIONS 319 18.4 RELATED REPORTS 319 18.5 AUTHOR DETAILS 320
圖表清單 List of Tables & Figures
TABLE 1 INCLUSIONS AND EXCLUSIONS 32 TABLE 2 US: FOOD RECALLS IN AND REASONS, 2023 44 TABLE 3 US: FOOD RECALLS, BY SPECIES, 2023 44 TABLE 4 TOP INNOVATIONS IN FOOD TESTING TECHNOLOGY 47 TABLE 5 INTERCONNECTED MARKETS 50 TABLE 6 KEY MOVES AND STRATEGIC FOCUS 51 TABLE 7 IMPACT OF PORTER’S FIVE FORCES ON MICROBIOLOGY TESTING MARKET 53 TABLE 8 GDP PERCENTAGE CHANGE, BY KEY COUNTRIES, 2023-2030 55 TABLE 9 NORTH AMERICA: MACROECONOMIC INDICATORS 56 TABLE 10 EUROPE: MACROECONOMIC INDICATORS 56 TABLE 11 ASIA PACIFIC: MACROECONOMIC INDICATORS 56 TABLE 12 LATIN AMERICA: MACROECONOMIC INDICATORS 57 TABLE 13 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 57 TABLE 14 MICROBIOLOGY TESTING MARKET: ROLE OF COMPANIES IN ECOSYSTEM 60 TABLE 15 AVERAGE SELLING PRICING TREND OF MICROBIOLOGY TESTING, BY PRODUCT, 2024–2026 (USD) 61 TABLE 16 AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING, BY KEY PLAYER, 2024–2026 (USD) 61 TABLE 17 AVERAGE SELLING PRICE TREND OF MICROBIOLOGY TESTING PRODUCTS, BY REGION, 2024–2026 (USD) 62 TABLE 18 IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 63 TABLE 19 EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 63 TABLE 20 MICROBIOLOGY TESTING MARKET: KEY CONFERENCES AND EVENTS, 2026–2027 64 TABLE 21 US-ADJUSTED RECIPROCAL TARIFF RATES 68 TABLE 22 LIST OF MAJOR PATENTS PERTAINING TO MICROBIOLOGY TESTING MARKET, 2023–2025 74 TABLE 23 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 24 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 25 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 26 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 27 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 28 GLOBAL STANDARDS IN THE MICROBIOLOGY TESTING MARKET 80 TABLE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 84 TABLE 30 KEY BUYING CRITERIA, BY PRODUCT 84 TABLE 31 ADOPTION BARRIERS & INTERNAL CHALLENGES 85 TABLE 32 MICROBIOLOGY TESTING MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 86 TABLE 33 MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 89 TABLE 34 KEY INSTRUMENTS IN MICROBIOLOGY TESTING INSTRUMENTS MARKET 90 TABLE 35 MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 91 TABLE 36 MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 91 TABLE 37 NORTH AMERICA: MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 92 TABLE 38 EUROPE: MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 92 TABLE 39 ASIA PACIFIC: MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 93 TABLE 40 LATIN AMERICA: MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 93 TABLE 41 MICROBIOLOGY TESTING INCUBATORS MARKET, BY REGION, 2024–2031 (USD MILLION) 94 TABLE 42 NORTH AMERICA: MICROBIOLOGY TESTING INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 94 TABLE 43 EUROPE: MICROBIOLOGY TESTING INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 95 TABLE 44 ASIA PACIFIC: MICROBIOLOGY TESTING INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 95 TABLE 45 LATIN AMERICA: MICROBIOLOGY TESTING INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 96 TABLE 46 MICROSCOPES MARKET, BY REGION, 2024–2031 (USD MILLION) 96 TABLE 47 NORTH AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 97 TABLE 48 EUROPE: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 97 TABLE 49 ASIA PACIFIC: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 97 TABLE 50 LATIN AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 98 TABLE 51 COLONY COUNTERS MARKET, BY REGION, 2024–2031 (USD MILLION) 98 TABLE 52 NORTH AMERICA: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 99 TABLE 53 EUROPE: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 99 TABLE 54 ASIA PACIFIC: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 100 TABLE 55 LATIN AMERICA: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 100 TABLE 56 MASS SPECTROMETERS MARKET, BY REGION, 2024–2031 (USD MILLION) 101 TABLE 57 NORTH AMERICA: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 101 TABLE 58 EUROPE: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 101 TABLE 59 ASIA PACIFIC: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 102 TABLE 60 LATIN AMERICA: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 102 TABLE 61 AUTOMATED CULTURE SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 103 TABLE 62 NORTH AMERICA: AUTOMATED CULTURE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 103 TABLE 63 EUROPE: AUTOMATED CULTURE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 104 TABLE 64 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR AUTOMATED CULTURE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 104 TABLE 65 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR AUTOMATED CULTURE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 105 TABLE 66 OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 105 TABLE 67 NORTH AMERICA: OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 106 TABLE 68 EUROPE: OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 106 TABLE 69 ASIA PACIFIC: OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 107 TABLE 70 LATIN AMERICA: OTHER MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 107 TABLE 71 KEY REAGENTS & KITS IN MICROBIOLOGY TESTING INSTRUMENTS MARKET 108 TABLE 72 MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 109 TABLE 73 NORTH AMERICA: MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 110 TABLE 74 EUROPE: MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 110 TABLE 75 ASIA PACIFIC: MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 111 TABLE 76 LATIN AMERICA: MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 111 TABLE 77 KEY CONSUMABLES IN MICROBIOLOGY TESTING INSTRUMENTS MARKET 112 TABLE 78 MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 113 TABLE 79 NORTH AMERICA: MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 113 TABLE 80 EUROPE: MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 114 TABLE 81 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 114 TABLE 82 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 115 TABLE 83 US: PHARMA INCUBATOR INSTALLED BASE VOLUME, 2024–2031 (UNITS) 116 TABLE 84 MICROBIOLOGY TESTING TECHNOLOGY MARKET, BY TECHNOLOGY TYPE, 2024–2031 (USD MILLION) 118 TABLE 85 TYPES OF TECHNOLOGIES USED IN VARIOUS TRADITIONAL MICROBIOLOGY METHODS (TMM) 119 TABLE 86 TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY TYPE, 2024–2031 (USD MILLION) 120 TABLE 87 TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY REGION, 2024–2031 (USD MILLION) 120 TABLE 88 NORTH AMERICA: TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121 TABLE 89 EUROPE: TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121 TABLE 90 ASIA PACIFIC: TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 122 TABLE 91 LATIN AMERICA: TRADITIONAL MICROBIOLOGY METHODS (TMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 122 TABLE 92 CULTURE METHODS MARKET, BY REGION, 2024–2031 (USD MILLION) 123 TABLE 93 NORTH AMERICA: CULTURE METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123 TABLE 94 EUROPE: CULTURE METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124 TABLE 95 ASIA PACIFIC: CULTURE METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124 TABLE 96 LATIN AMERICA: CULTURE METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125 TABLE 97 MICROSCOPY METHODS MARKET, BY REGION, 2024–2031 (USD MILLION) 126 TABLE 98 NORTH AMERICA: MICROSCOPY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126 TABLE 99 EUROPE: MICROSCOPY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126 TABLE 100 ASIA PACIFIC: MICROSCOPY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 101 LATIN AMERICA: MICROSCOPY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 102 MANUAL COUNTING METHODS MARKET, BY REGION, 2024–2031 (USD MILLION) 128 TABLE 103 NORTH AMERICA: MANUAL COUNTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 128 TABLE 104 EUROPE: MANUAL COUNTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 105 ASIA PACIFIC: MANUAL COUNTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 106 LATIN AMERICA: MANUAL COUNTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130 TABLE 107 STAINING TECHNIQUES MARKET, BY REGION, 2024–2031 (USD MILLION) 131 TABLE 108 NORTH AMERICA: STAINING TECHNIQUES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131 TABLE 109 EUROPE: STAINING TECHNIQUES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131 TABLE 110 ASIA PACIFIC: STAINING TECHNIQUES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 111 LATIN AMERICA: STAINING TECHNIQUES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 112 OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY REGION, 2024–2031 (USD MILLION) 133 TABLE 113 NORTH AMERICA: OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 114 EUROPE: OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 115 ASIA PACIFIC: OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 116 LATIN AMERICA: OTHER TRADITIONAL MICROBIOLOGY METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 117 TYPES OF TECHNOLOGIES USED IN VARIOUS RAPID MICROBIOLOGY METHODS (RMM) 136 TABLE 118 RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY TYPE, 2024–2031 (USD MILLION) 136 TABLE 119 RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY REGION, 2024–2031 (USD MILLION) 137 TABLE 120 NORTH AMERICA: RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 137 TABLE 121 EUROPE: RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 122 ASIA PACIFIC: RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 123 LATIN AMERICA: RAPID MICROBIOLOGY METHODS (RMM) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 124 GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 140 TABLE 125 NORTH AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 126 EUROPE: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 127 ASIA PACIFIC: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 128 LATIN AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 129 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 143 TABLE 130 NORTH AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 143 TABLE 131 EUROPE: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 132 ASIA PACIFIC: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 133 LATIN AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 134 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 146 TABLE 135 NORTH AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 136 EUROPE: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 137 ASIA PACIFIC: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 138 LATIN AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 139 VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 149 TABLE 140 NORTH AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 141 EUROPE: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 142 ASIA PACIFIC: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 143 LATIN AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 144 MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 153 TABLE 145 BACTERIAL TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 154 TABLE 146 NORTH AMERICA: BACTERIAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 147 EUROPE: BACTERIAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 148 ASIA PACIFIC: BACTERIAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 149 LATIN AMERICA: BACTERIAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 150 VIRAL TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 156 TABLE 151 NORTH AMERICA: VIRAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 152 EUROPE: VIRAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 153 ASIA PACIFIC: VIRAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 154 LATIN AMERICA: VIRAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 155 FUNGAL TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 158 TABLE 156 NORTH AMERICA: FUNGAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 157 EUROPE: FUNGAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 158 ASIA PACIFIC: FUNGAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 159 LATIN AMERICA: FUNGAL TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 160 OTHER PATHOGEN TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 160 TABLE 161 NORTH AMERICA: OTHER PATHOGEN TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 160 TABLE 162 EUROPE: OTHER PATHOGEN TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 160 TABLE 163 ASIA PACIFIC: OTHER PATHOGEN TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 164 LATIN AMERICA: OTHER PATHOGEN TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 165 MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 163 TABLE 166 MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2024–2031 (USD MILLION) 164 TABLE 167 NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 168 EUROPE: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 169 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 170 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 171 MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024–2031 (USD MILLION) 166 TABLE 172 NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 173 EUROPE: MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 174 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 175 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 176 MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY REGION, 2024–2031 (USD MILLION) 169 TABLE 177 NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 178 EUROPE: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 179 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 180 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 181 MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY REGION, 2024–2031 (USD MILLION) 171 TABLE 182 NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 183 EUROPE: MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 184 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 185 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 186 MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 174 TABLE 187 NORTH AMERICA: MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 188 EUROPE: MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 189 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 190 LATIN AMERICA: MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 191 MICROBIOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 178 TABLE 192 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 193 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 180 TABLE 194 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 180 TABLE 195 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 180 TABLE 196 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY END USERS, 2024–2031 (USD MILLION) 181 TABLE 197 US: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 182 TABLE 198 US: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 182 TABLE 199 US: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 182 TABLE 200 US: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 183 TABLE 201 CANADA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 184 TABLE 202 CANADA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 184 TABLE 203 CANADA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 185 TABLE 204 CANADA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 185 TABLE 205 EUROPE: MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 206 EUROPE: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 186 TABLE 207 EUROPE: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 187 TABLE 208 EUROPE: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 187 TABLE 209 EUROPE: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 188 TABLE 210 GERMANY: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 189 TABLE 211 GERMANY: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 189 TABLE 212 GERMANY: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 189 TABLE 213 GERMANY: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 190 TABLE 214 UK: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 191 TABLE 215 UK: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 191 TABLE 216 UK: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 191 TABLE 217 UK: MICROBIOLOGY TESTING MARKET, BY END USERS, 2024–2031 (USD MILLION) 192 TABLE 218 FRANCE: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 193 TABLE 219 FRANCE: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 193 TABLE 220 FRANCE: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 193 TABLE 221 FRANCE: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 194 TABLE 222 ITALY: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 195 TABLE 223 ITALY: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 195 TABLE 224 ITALY: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 195 TABLE 225 ITALY: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 196 TABLE 226 SPAIN: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 197 TABLE 227 SPAIN: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 197 TABLE 228 SPAIN: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 197 TABLE 229 SPAIN: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 198 TABLE 230 REST OF EUROPE: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 198 TABLE 231 REST OF EUROPE: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 199 TABLE 232 REST OF EUROPE: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 199 TABLE 233 REST OF EUROPE: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 200 TABLE 234 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 202 TABLE 235 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 202 TABLE 236 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 203 TABLE 237 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 203 TABLE 238 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 204 TABLE 239 CHINA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 205 TABLE 240 CHINA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 205 TABLE 241 CHINA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 205 TABLE 242 CHINA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 206 TABLE 243 JAPAN: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 207 TABLE 244 JAPAN: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 207 TABLE 245 JAPAN: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 207 TABLE 246 JAPAN: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 208 TABLE 247 INDIA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 209 TABLE 248 INDIA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 209 TABLE 249 INDIA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 209 TABLE 250 INDIA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 210 TABLE 251 SOUTH KOREA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 211 TABLE 252 SOUTH KOREA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 211 TABLE 253 SOUTH KOREA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 211 TABLE 254 SOUTH KOREA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 212 TABLE 255 AUSTRALIA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 213 TABLE 256 AUSTRALIA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 213 TABLE 257 AUSTRALIA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 213 TABLE 258 AUSTRALIA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 214 TABLE 259 REST OF ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 214 TABLE 260 REST OF ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 215 TABLE 261 REST OF ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 215 TABLE 262 REST OF ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 216 TABLE 263 LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 217 TABLE 264 LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 217 TABLE 265 LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 217 TABLE 266 LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 218 TABLE 267 LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 218 TABLE 268 BRAZIL: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 219 TABLE 269 BRAZIL: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 219 TABLE 270 BRAZIL: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 219 TABLE 271 BRAZIL: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 220 TABLE 272 MEXICO: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 221 TABLE 273 MEXICO: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 221 TABLE 274 MEXICO: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 221 TABLE 275 MEXICO: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 222 TABLE 276 REST OF LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 222 TABLE 277 REST OF LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 223 TABLE 278 REST OF LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 223 TABLE 279 REST OF LATIN AMERICA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 224 TABLE 280 MIDDLE EAST & AFRICA: MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 225 TABLE 281 MIDDLE EAST & AFRICA: MICROBIOLOGY TESTING MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 225 TABLE 282 MIDDLE EAST & AFRICA: MICROBIOLOGY TESTING MARKET, BY PATHOGEN TYPE, 2024–2031 (USD MILLION) 225 TABLE 283 MIDDLE EAST & AFRICA: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031 (USD MILLION) 226 TABLE 284 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 227 TABLE 285 MICROBIOLOGY TESTING MARKET: DEGREE OF COMPETITION 230 TABLE 286 REGIONAL FOOTPRINT, 2025 234 TABLE 287 PRODUCT FOOTPRINT, 2025 235 TABLE 288 TECHNOLOGY FOOTPRINT 235 TABLE 289 END USER FOOTPRINT, 2025 236 TABLE 290 LIST OF STARTUPS/SMES, 2025 239 TABLE 291 MICROBIOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2), 2025 239 TABLE 292 MICROBIOLOGY TESTING MARKET COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2), 2025 240 TABLE 293 MICROBIOLOGY TESTING MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–DECEMBER 2025 242 TABLE 294 MICROBIOLOGY TESTING MARKET: DEALS, JANUARY 2022–DECEMBER 2025 243 TABLE 295 MICROBIOLOGY TESTING MARKET: EXPANSION, JANUARY 2022–DECEMBER 2025 243 TABLE 296 BIOMÉRIEUX: COMPANY OVERVIEW 244 TABLE 297 BIOMÉRIEUX: PRODUCTS OFFERED 245 TABLE 298 BIOMÉRIEUX: PRODUCT LAUNCHES AND APPROVALS 246 TABLE 299 BIOMÉRIEUX: DEALS 247 TABLE 300 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 249 TABLE 301 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 250 TABLE 302 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES AND APPROVALS 251 TABLE 303 MERCK KGAA: COMPANY OVERVIEW 253 TABLE 304 MERCK KGAA: PRODUCTS/SERVICES OFFERED 254 TABLE 305 MERCK KGAA: PRODUCT LAUNCHES 255 TABLE 306 MERCK KGAA: DEALS 255 TABLE 307 MERCK KGAA: EXPANSIONS 256 TABLE 308 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW 258 TABLE 309 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED 260 TABLE 310 BECKTON, DICKINSON AND COMPANY: EXPANSIONS 260 TABLE 311 NEOGEN CORPORATION: COMPANY OVERVIEW 262 TABLE 312 NEOGEN CORPORATION: PRODUCTS/SERVICES OFFERED 263 TABLE 313 NEOGEN CORPORATION: PRODUCT/SERVICE LAUNCHES 264 TABLE 314 NEOGEN CORPORATION: DEALS 265 TABLE 315 QIAGEN: COMPANY OVERVIEW 266 TABLE 316 MCKESSON CORPORATION: PRODUCTS OFFERED 267 TABLE 317 QIAGEN N.V.: PRODUCT LAUNCHES 268 TABLE 318 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 269 TABLE 319 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED 270 TABLE 320 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES 271 TABLE 321 BRUKER: COMPANY OVERVIEW 272 TABLE 322 BRUKER: PRODUCTS/SERVICES OFFERED 273 TABLE 323 BRUKER: DEALS 274 TABLE 324 SHIMADZU CORPORATION: COMPANY OVERVIEW 275 TABLE 325 SHIMADZU CORPORATION: PRODUCTS/SERVICES OFFERED 276 TABLE 326 SHIMADZU CORPORATION: PRODUCT/SERVICE LAUNCHES AND APPROVALS 277 TABLE 327 SHIMADZU CORPORATION: EXPANSIONS 277 TABLE 328 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 278 TABLE 329 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED 279 TABLE 330 CHARLES RIVER LABORATORIES: PRODUCT/SERVICE LAUNCHES 280 TABLE 331 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 281 TABLE 332 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED 282 TABLE 333 EUROFINS SCIENTIFIC: DEALS 283 TABLE 334 IDEXX: COMPANY OVERVIEW 284 TABLE 335 IDEXX: PRODUCTS/SERVICES OFFERED 285 TABLE 336 IDEXX: PRODUCT/SERVICE LAUNCHES AND APPROVALS 286 TABLE 337 HARDY DIAGNOSTICS: COMPANY OVERVIEW 287 TABLE 338 CHARM SCIENCES: COMPANY OVERVIEW 288 TABLE 339 MICROBIOLOGICS: COMPANY OVERVIEW 289 TABLE 340 LIOFILCHEM S.R.L. : COMPANY OVERVIEW 290 TABLE 341 R-BIOPHARM: COMPANY OVERVIEW 291 TABLE 342 ROMER LABS DIVISION HOLDING: COMPANY OVERVIEW 292 TABLE 343 HYGIENA LLC: COMPANY OVERVIEW 293 TABLE 344 HIMEDIA LABORATORIES: COMPANY OVERVIEW 294 TABLE 345 CONDALAB: COMPANY OVERVIEW 295 TABLE 346 E&O LABORATORIES LTD: COMPANY OVERVIEW 296 TABLE 347 MAST GROUP LTD.: COMPANY OVERVIEW 297 TABLE 348 MEDICAL WIRE & EQUIPMENT: COMPANY OVERVIEW 298 TABLE 349 HACH: COMPANY OVERVIEW 299 TABLE 350 MICROBIOLOGY TESTING MARKET: KEY DATA FROM PRIMARY SOURCES 304 TABLE 351 RISK ASSESSMENT 312 FIGURE 1 MICROBIOLOGY TESTING MARKET SEGMENTATION 31 FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 34 FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MICROBIOLOGY TESTING MARKET, 2022–2025 35 FIGURE 4 DISRUPTIVE TRENDS IMPACTING GROWTH OF MICROBIOLOGY TESTING MARKET 35 FIGURE 5 FASTEST-GROWTH SEGMENTS AND EMERGING FRONTIERS IN MICROBIOLOGY TESTING MARKET 36 FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 37 FIGURE 7 GROWING NEED FOR CONTAMINATION CONTROL TO DRIVE MARKET 38 FIGURE 8 REAGENT & KITS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 38 FIGURE 9 TRADITIONAL MICROBIOLOGY METHODS (TMM) TO LEAD MARKET DURING FORECAST PERIOD 39 FIGURE 10 BACTERIAL TESTING TO CONTINUE LEAD SIGNIFICANTLY DURING FORECAST PERIOD 39 FIGURE 11 PHARMACEUTICAL & BIOTECH COMPANIES TO COMMAND LARGEST SHARE AMONG END USERS DURING FORECAST PERIOD 40 FIGURE 12 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 40 FIGURE 13 MICROBIOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41 FIGURE 14 PRODUCTS RECALLED GLOBALLY, 2012–2022 43 FIGURE 15 MICROBIOLOGY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS 52 FIGURE 16 MICROBIOLOGY TESTING MARKET: SUPPLY CHAIN ANALYSIS 58 FIGURE 17 MICROBIOLOGY TESTING MARKET: VALUE CHAIN ANALYSIS 59 FIGURE 18 MICROBIOLOGY TESTING MARKET: ECOSYSTEM ANALYSIS 60 FIGURE 19 MICROBIOLOGY TESTING MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 65 FIGURE 20 NUMBER OF DEALS & FUNDING ACTIVITIES IN MICROBIOLOGY TESTING MARKET 66 FIGURE 21 PATENT ANALYSIS FOR MICROBIOLOGY TESTING, JANUARY 2016–DECEMBER 2025 73 FIGURE 22 MARKET POTENTIAL OF AI IN MICROBIOLOGY TESTING MARKET 75 FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 83 FIGURE 24 KEY BUYING CRITERIA, BY PRODUCT 84 FIGURE 25 NORTH AMERICA: MICROBIOLOGY TESTING MARKET SNAPSHOT 179 FIGURE 26 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET SNAPSHOT 201 FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD MILLION) 229 FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 230 FIGURE 29 US MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 231 FIGURE 30 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 233 FIGURE 31 COMPANY FOOTPRINT, 2025 234 FIGURE 32 COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 238 FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK BETA OF KEY VENDORS, 2025 240 FIGURE 34 EV/EBITDA OF KEY VENDORS, 2025 241 FIGURE 35 BRAND/PRODUCT COMPARATIVE ANALYSIS 241 FIGURE 36 BIOMÉRIEUX: COMPANY SNAPSHOT (2024) 245 FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 250 FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2024) 254 FIGURE 39 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024) 259 FIGURE 40 NEOGEN CORPORATION: COMPANY SNAPSHOT (2024) 263 FIGURE 41 QIAGEN: COMPANY SNAPSHOT (2024) 267 FIGURE 42 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 270 FIGURE 43 BRUKER: COMPANY SNAPSHOT (2024) 273 FIGURE 44 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2024) 276 FIGURE 45 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024) 279 FIGURE 46 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024) 282 FIGURE 47 IDEXX: COMPANY SNAPSHOT (2024) 285 FIGURE 48 MICROBIOLOGY TESTING MARKET: RESEARCH DESIGN METHODOLOGY 300 FIGURE 49 KEY DATA FROM SECONDARY SOURCES 302 FIGURE 50 PRIMARY SOURCES 303 FIGURE 51 INSIGHTS FROM INDUSTRY EXPERTS 305 FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 306 FIGURE 53 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION 306 FIGURE 54 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 307 FIGURE 55 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 308 FIGURE 56 MICROBIOLOGY TESTING MARKET: TOP-DOWN APPROACH 309 FIGURE 57 DATA TRIANGULATION METHODOLOGY 310 FIGURE 58 MICROBIOLOGY TESTING MARKET: RESEARCH ASSUMPTIONS 311

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們